Outcomes of oral antidiabetic drugs in metabolic dysfunction-associated steatotic liver disease: a nationwide target trial emulation study.

Clin Mol Hepatol · 2026 · PMC13129748 · PMID 41492191

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

SGLT2 inhibitor use suggested a protective trend against myocardial infarction compared to sulfonylureas (aSHR, 0.61; 95% CI, 0.36–1.03), which did not reach statistical significance ( Fig. 2C and Supplementary Table 5 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.